These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35084654)
21. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Citraro R; Leo A; Constanti A; Russo E; De Sarro G Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136 [TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging. van Vliet EA; Otte WM; Wadman WJ; Aronica E; Kooij G; de Vries HE; Dijkhuizen RM; Gorter JA Epilepsia; 2016 Jan; 57(1):59-69. PubMed ID: 26691904 [TBL] [Abstract][Full Text] [Related]
37. Brain somatic mutations in MTOR leading to focal cortical dysplasia. Lim JS; Lee JH BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999 [TBL] [Abstract][Full Text] [Related]
38. GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Buller CL; Heilig CW; Brosius FC Am J Physiol Renal Physiol; 2011 Sep; 301(3):F588-96. PubMed ID: 21613414 [TBL] [Abstract][Full Text] [Related]
39. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury. van Vliet EA; Ndode-Ekane XE; Lehto LJ; Gorter JA; Andrade P; Aronica E; Gröhn O; Pitkänen A Neurobiol Dis; 2020 Nov; 145():105080. PubMed ID: 32919030 [TBL] [Abstract][Full Text] [Related]
40. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]